Phoenix is the world's most trusted software platform for comprehensive PK/PD, toxicokinetic (TK), and in vitro–in vivo correlation (IVIVC) modeling and simulation. It is the industry gold standard, used by over 2,600 companies and 11,000 users worldwide, with companies using Phoenix accounting for 90% of novel drugs approved by the US FDA.
The platform, which includes core modules like Phoenix WinNonlin (for Noncompartmental Analysis) and Phoenix NLME (for Non-Linear Mixed Effects/Population PK/PD), provides an all-in-one collaboration workbench for scientists, reviewers, medical writers, and quality assurance teams. Key capabilities include Noncompartmental Analysis (NCA), Population PK/PD modeling (NLME) with sophisticated algorithms, and Bioequivalence/Bioavailability studies.
Phoenix is designed for regulatory compliance, featuring validated analytical workflows, transparent and auditable outputs, and alignment with FDA 21 CFR Part 11, GCP, and CDISC standards. The software is available as a traditional desktop application and a cloud-hosted solution (Phoenix Hosted) that offers Single Sign-On (SSO), centralized access control, and reduced IT burden. It expedites workflows from data preparation to generating submission-ready Tables, Figures, and Listings (TFLs).